Ruth Ellis

Dr. Ellis is a consultant on clinical and regulatory strategy for development of biologics for broad range of indications.

Experience with vaccines, cell and gene therapy, blood products, monoclonal antibodies, and biosimilars. She has designed and executed of clinical trials to evaluate safety, immunogenicity, and efficacy of vaccines for global health, including innovative proof of concept studies for assessment of biologic impact of tuberculosis and malaria vaccines.